Open Access
CC BY-NC-ND 4.0 · International Journal of Epilepsy 2023; 09(01/02): A1-A40
DOI: 10.1055/s-0044-1791426
E-Poster Abstracts

Economic Burden and Intervention for Pharmacological Management of Drug-Resistant Epilepsy in Primary Health Care Settings: A Study Protocol for a CRT That Uses an Incentive-Based Approach to Lower Seizure Frequency

Authors

  • Utpal Kumar Gogoi

    1   Dayanand Medical College and Hospital, Ludhiana, Punjab, India

  • Sarit Sharma

    1   Dayanand Medical College and Hospital, Ludhiana, Punjab, India

  • Gagandeep Singh

    1   Dayanand Medical College and Hospital, Ludhiana, Punjab, India

  • Susmita Chatterje

    2   George Institute for Global Health, New Delhi, India
Further Information
Also available at
 

Introduction: Despite the development of new antiseizure medicines, 30.6% of people are drug-resistant and therefore are more at risk to premature death, injuries and mental health issues. Drug-resistant epilepsy patients require a great deal of time and effort from treating physicians and also represent a huge economic burden. To help achieve a reduction of seizure frequency for an adequate period of time, be selected appropriately for the individual's seizure or epilepsy type, and be prescribed at a sufficient dose is a challenging task.

Aim of the Study: To identify and develop innovative means to incentivize recipients with drug-resistant epilepsy care.

Primary Objective: To determine whether cost sharing through a financial incentive scheme leads to reduction in seizure frequency among drug-resistant epilepsy people.

Secondary Objective: To determine the financial burden of a person with drug-resistant epilepsy. To determine the impact of cost sharing on retention rate, medication adherence, and quality of life of drug-resistant epilepsy people in primary health centers.

Materials and Methods: Study will be a prospective open label cluster randomized trial of financial incentivization of people with drug-resistant epilepsy. The cluster unit will comprise people attending primary health centers. Study will be performed at the site Nawanshahr (Punjab).

Clinical Significance: To reduce the epilepsy burden and high cost of care in India the intervention of incentivization would reduce the seizure frequency and increase the retention rates, medication adherence and quality of life of people with drug-resistant epilepsy.



Publication History

Article published online:
12 September 2024

© 2023. Indian Epilepsy Society. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India